Medical assessment + personalised protocol — Book now →
Guides29 July 20267 min read

Injectable glutathione: benefits, reviews and contraindications (medical guide)

What injectable glutathione is, how it differs from the oral form, which benefits are supported by evidence, what people who have tried it say and in which situations it is not indicated.

English translation of content medically reviewed in Romanian by Dr. Claudiu Ruscu, intensive care physician (anaesthesia & intensive care)· Romanian text reviewed 29 July 2026

Injectable glutathione: benefits, reviews and contraindications (medical guide)

Injectable glutathione is searched for a lot, but the information online is split between adverts and forums. This guide brings together what is known: what glutathione does, why the injectable route differs from the oral one, what people who have tried it say and — more importantly — when it is not indicated.

What glutathione is

Glutathione is a tripeptide produced naturally by the liver, made of three amino acids: cysteine, glycine and glutamic acid. It is considered the main intracellular antioxidant — it takes part in neutralising free radicals and in the processes by which the body handles substances it wants to get rid of.

It is not a miracle drug and it does not treat any particular disease. It is a molecule the body makes on its own, whose level can fall with age, with oxidative stress or in certain conditions.

Injectable vs oral: why the route matters

This is the main practical difference, and it is an argument about bioavailability, not about guaranteed efficacy.

Glutathione taken by mouth is largely broken down in the digestive tract before it reaches the circulation. That is why oral glutathione supplements are poorly absorbed, and some manufacturers recommend precursors such as NAC instead — see the detailed comparison in NAC and glutathione.

Glutathione given intravenously bypasses digestion and goes straight into the bloodstream. That means a higher plasma concentration, more quickly. What it does not mean: that the effects you feel are automatically greater or guaranteed.

> Better bioavailability is a measurable fact. The clinical benefit you feel is individual and depends on context, not on the route of administration itself.

Which benefits are discussed

The reasons people choose a glutathione drip, as they are usually put:

  • Antioxidant support — the molecule's main, documented role.
  • Liver support — the liver is the organ where glutathione is produced and heavily used.
  • Skin appearance — the most searched-for reason online and, at the same time, the most oversold. See the section below.
  • Recovery after exertion or demanding periods — as part of a broader protocol, not as a stand-alone solution.

What you will not find here: promises of cure, “complete” detoxification or guaranteed results. The body has its own elimination mechanisms, and a drip supports them — it does not replace them. We have covered separately what a drip can and cannot do in detox: myths and reality.

About the effect on skin — the honest part

Most searches for “injectable glutathione” come from the aesthetic side, where the molecule is promoted for lightening skin tone. Precision is needed here:

The depigmenting effect has been studied, but the evidence is limited in the number and size of studies, and results vary widely from person to person. There is no medical consensus supporting injectable glutathione as a skin-whitening treatment, and several regulators have issued warnings about its use for this purpose, especially at high doses and without supervision.

If this is the main reason you are looking into it, an honest conversation with a doctor is more useful than any article.

What people who have tried it say

Opinions shared publicly generally fall into three groups:

  • “I felt more energy and slept better” — the most frequently reported. Hard to separate from the effect of the rest of the protocol (hydration, vitamins) or from the context in which people choose to have a drip.
  • “I didn't feel anything special” — just as frequent, and entirely plausible. If your glutathione level is within normal parameters, an extra supply does not necessarily produce a change you can feel.
  • “It felt expensive for what I noticed” — a legitimate observation, which comes down to expectations. That is why it matters that someone tells you beforehand what is realistic.
  • Opinions are personal accounts, not clinical evidence. We mention them because they are exactly what people look for — but a medical decision is not made on their basis.

    How a glutathione drip goes

    A short medical assessment, placing the IV line, the administration itself — usually 15–20 minutes for the standard protocols — and a short observation period. It is not a painful procedure; the sensation is that of a prick when the cannula goes in.

    Contraindications and when it is NOT indicated

    This is the part missing from most articles on the subject.

    • Pregnancy and breastfeeding — it is not given.
    • Asthma — reactions to sulphur compounds have been reported; careful assessment is needed.
    • Known allergy to glutathione or to the components of the solution.
    • Severe kidney or liver disease — requires a prior medical assessment and, often, postponement.
    • Active cancer treatment — glutathione may interfere with certain therapies; the decision belongs to the treating doctor, not the IV drip clinic.
    • Children and adolescents — not a routine indication.

    The list is not exhaustive. That is why a medical assessment before administration is not a formality, but a condition.

    How much it costs

    At SYNERVA, the glutathione IV drip is available in two strengths: 600 mg — 250 RON and Glutathione 1200 mg — 400 RON, with the medical assessment included in the price. There is also the combined Glutathione + vitamin C, at 450 RON. Prices are published in full, with no costs added later.

    Conclusion

    Injectable glutathione has real logic behind it — better bioavailability than the oral form and a documented antioxidant role. It does not, however, have the treatment status some online promotion attributes to it, and for the aesthetic indication the evidence remains limited.

    If you are interested, the right step is a medical assessment: we will tell you whether it makes sense in your situation and, just as importantly, when it does not.

    More in Guides

    References

    The studies below support the statements on mechanism, pharmacokinetics and safety on this page. They do not support a guaranteed therapeutic outcome — each one is followed by its limitation.

    1. [1] Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013.

      narrative review · PMID 22995213

      Limitation: Recenzie narativă de biochimie, fără metodă sistematică. Descrie glutationul produs de organism și reglarea sintezei lui, nu efectul glutationului administrat din afară.

    2. [2] Sekhar RV, Patel SG, Guthikonda AP, et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. 2011.

      observational study · sample: 16 · PMID 21795440

      Limitation: Doar 16 persoane; partea de suplimentare nu are grup de control. Glutationul a fost măsurat doar în eritrocite. Studiul a folosit precursori orali, nu glutation injectabil.

    3. [3] Sinha R, Sinha I, Calcagnotto A, et al. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr. 2018.

      case series · sample: 12 · PMID 28853742

      Limitation: Doar 12 persoane, fără grup placebo, o lună. Studiul a fost finanțat de Researched Nutritionals, firma care vinde glutationul lipozomal testat. Rezultatele sunt markeri de laborator, nu beneficii clinice.

    4. [4] Cascinu S, Cordella L, Del Ferro E, et al. Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial. J Clin Oncol. 1995.

      randomised trial · sample: 50 · PMID 7799029

      Limitation: Doar 50 de pacienți, un singur tip de cancer, din 1995. Rata de răspuns a fost un rezultat secundar, fără putere statistică. Un studiu mai mare (Leal 2014, carboplatină/paclitaxel) nu a confirmat beneficiul neuroprotector.

    5. [5] Traverso N, Ricciarelli R, Nitti M, et al. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev. 2013.

      narrative review · PMID 23766865

      Limitation: Recenzie narativă despre glutationul din interiorul celulelor tumorale, nu despre glutationul administrat intravenos pacienților. Abstractul nu prezintă date clinice de interferență cu tratamentul.

    6. [6] Forman HJ, Zhang H, Rinna A Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009.

      narrative review · PMID 18796312

      Limitation: A short narrative biochemistry review, the introduction to a themed issue. It describes the function of the glutathione the body produces, not the effect of glutathione given from outside. It does not discuss the liver specifically.

    7. [7] Witschi A, Reddy S, Stofer B, et al. The systemic availability of oral glutathione. Eur J Clin Pharmacol. 1992.

      case series · sample: 7 · PMID 1362956

      Limitation: Only 7 volunteers and a single dose, followed for 4.5 hours. It did not test long-term daily use, which gave a different result in a 2015 randomised trial (Richie). Analytical methods from 1992.

    8. [8] Richie JP Jr, Nichenametla S, Neidig W, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015.

      randomised trial · sample: 54 · PMID 24791752

      Limitation: The outcome is a marker (the glutathione level), not a clinical benefit. The participants were healthy adults, and the effect disappeared after a one-month break. The study does not compare with intravenous administration.

    9. [9] Aebi S, Assereto R, Lauterburg BH High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine. Eur J Clin Invest. 1991.

      case series · sample: 10 · PMID 1907548

      Limitation: A single, high dose (2 g/m², about 3.5 g, 3–6 times above Synerva's protocols), in 10 volunteers. Glutathione inside the cells was not measured, and the methods date from 1991.

    10. [10] Marrades RM, Roca J, Barberà JA, et al. Nebulized glutathione induces bronchoconstriction in patients with mild asthma. Am J Respir Crit Care Med. 1997.

      randomised trial · sample: 8 · PMID 9279219

      Limitation: The route is inhaled, not intravenous, so its relevance to the drip is indirect. Only 8 patients. It supports caution in asthma, not a reaction rate for IV administration.

    11. [11] Sarkar R, Yadav V, Yadav T, et al. Glutathione as a skin-lightening agent and in melasma: a systematic review. Int J Dermatol. 2025.

      systematic review · PMID 39444151

      Limitation: The search covered only the last 10 years, and the included studies are small, half of them at high risk of bias. For the IV route there is a single study with 16 people per arm. Most of the data concern the oral and topical forms.

    12. [12] Sonthalia S, Daulatabad D, Sarkar R Glutathione as a skin whitening agent: Facts, myths, evidence and controversies. Indian J Dermatol Venereol Leprol. 2016.

      narrative review · PMID 27088927

      Limitation: A narrative review, not a systematic one. For the FDA Philippines warning it is a secondary source: the number and date of the warning are not given in the abstract. Adverse effects are not quantified.

    SYNERVA services related to this article

    Thinking of trying it?

    We start with a medical assessment — we tell you which protocol makes sense for you and which doesn't. Published prices, no surprises.

    Book an assessment

    We use necessary cookies and, only with your consent, analytics and marketing cookies. Details

    WhatsAppMapPhoneBook